No Data
No Data
Nurix Therapeutics to Participate in the Jefferies Global Healthcare Conference
SAN FRANCISCO, May 29, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat pat
Express News | Nurix Therapeutics Appoints Paula G. O’connor, M.d., as Chief Medical Officer and Pasit Phiasivongsa, Ph.d., as Chief Technical Officer
Viking, CRISPR, Intellia Among Potential M&A Targets: Wells Fargo
Express News | Nurix Therapeutics Says David Lacey Steps Down From Chair Role And Will Remain Board Member And Retain Committee Leadership Roles; Current Board Member Julia Gregory Elected New Board Chair
Express News | Nurix Therapeutics Inc: David L. Lacey Steps Down From Chair Role and Will Remain Board Member and Retain Committee Leadership Roles
Express News | Nurix Therapeutics Inc: Current Board Member Julia P. Gregory Unanimously Elected New Board Chair